Results 161 to 170 of about 3,775,993 (302)

RESEARCH: Effects of Long‐Term Disease‐Modifying Antirheumatic Drugs on Endothelial Function in Patients with Early Rheumatoid Arthritis [PDF]

, 2010
M. Turiel, L. Tomasoni, S. Sitia, Silvana Cicala, L. Gianturco, Cristian Ricci, Fabiola Atzeni, Vito De Gennaro Colonna, Mariangela Longhi, Piercarlo Sarzi‐Puttini   +9 more
openalex   +1 more source

Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework. [PDF]

Rheumatol Int
Cheng V, Amiri N, Cheng V, Ellis U, Cragg JJ, Proulx L, Tucker DR, De Vera MA.   +7 more
europepmc   +1 more source

Recommendations for the Use of Disease-Modifying Antirheumatic Drugs in Pregnancy and Reproductive Health for Patients With Rheumatic Disease: A Scoping Review. [PDF]

Arthritis Care Res (Hoboken)
Chin A, Terrett A, Kwon M, Whittle S, Hill C.   +4 more
europepmc   +1 more source

ANTIRHEUMATIC DRUGS IN PREGNANCY AND LACTATION [PDF]

Rheumatology, 1985
openaire   +3 more sources

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial [PDF]

, 2010
Vappu Rantalaiho, Markku Korpela, Leena Laasonen, Hannu Kautiainen, Salme Järvenpää, Pekka Hannonen, Marjatta Leirisalo‐Repo, Harri Blåfield, Kari Puolakka, Anna Karjalainen, Timo Möttönen   +10 more
openalex   +1 more source

Impact of seropositivity and disease-modifying antirheumatic drugs on pulmonary tuberculosis risk in rheumatoid arthritis. [PDF]

ERJ Open Res
Choi H, Eun Y, Han K, Jung JH, Jung W, Kim H, Shin DW, Lee H.   +7 more
europepmc   +1 more source

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature [PDF]

, 2011
Maurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, Piercarlo Sarzi‐Puttini, Fabiola Atzeni   +4 more
openalex   +1 more source

Profiles and influencing factors of pulmonary fibrosis associated with biologic and conventional disease-modifying antirheumatic drugs for autoimmune diseases: a disproportionality study based on FAERS and VigiAccess. [PDF]

Front Pharmacol
Zhang X, Wu X, Luo C, Yang C, Jia N, He J, Chen Q, Wang F.   +7 more
europepmc   +1 more source

A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis

Journal of Rheumatology, 2018
S. Subesinghe, K. Bechman, A. Rutherford, D. Goldblatt, J. Galloway   +4 more
semanticscholar   +1 more source

Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs [PDF]

, 2011
Vivian P. Bykerk, Pooneh Akhavan, Glen Hazlewood, Orit Schieir, Anne Dooley, Boulos Haraoui, Majed Khraishi, Sharon LeClercq, Jean Légaré, DIANE P. MOSHER, James Pencharz, Janet Pope, John Thomson, Carter Thorne, Michel Zummer, Claire Bombardier   +15 more
openalex   +1 more source